| 000 | 01118nam a2200337Ia 4500 | ||
|---|---|---|---|
| 001 | 004978 | ||
| 008 | 141222s9999 xx 000 0 und d | ||
| 020 | _a92-832-1267-3 | ||
| 022 | _a0250-9555 | ||
| 040 | _aDB/INS | ||
| 041 | 0 | _aeng | |
| 084 | _aWHO | ||
| 084 | _bIARC V.67 | ||
| 110 | 2 | _a11-18 Jun. 1996 | |
| 111 | 2 | _aIARC Working Group on the Evaluation of Carcinogenic Risk to Humans | |
| 111 | 2 | _cLyon, Francia | |
| 111 | 2 | _d11-18 Jun. 1996 | |
| 245 | 1 | 0 | _aHuman immunodeficiency viruses and human T-cell lymphotropic viruses |
| 245 | 1 | 0 | _cWorld Health Organization, International Agency for Research on Cancer |
| 260 | _aLyon | ||
| 260 | _bIARC | ||
| 260 | _c1996 | ||
| 300 | _axii, 424 | ||
| 300 | _btbls.; ilus | ||
| 440 | 0 | _aIARC monographs on the evaluation of carcinogenic risks to Humans, 67 | |
| 500 | _aIntituciones patrocinadoras: World Health Organization, International Agency for Research on Cancer | ||
| 650 | 1 | _aSíndrome de inmunodeficiencia adquirida | |
| 650 | 2 | _aCongresos | |
| 650 | 2 | _aVirus oncogénicos | |
| 710 | 2 | _aInternational Agency for Research on Cancer | |
| 999 |
_c14401 _d14401 |
||